S. 150 aims to modify the Federal Trade Commission Act to stop product hopping. The bill introduces changes to patent laws concerning biological products, restricting the number of patents that can be asserted in infringement cases and specifying conditions under which courts...
Simple Explanation
S. 150 is like a rule that tries to stop companies from sneaking around with medicine products, and it also gives a lot of money to help make a health program called Medicare better.